ESMO 2022 - NICHE-2 and Codebreak 200
from OncoPharm Hosted by John Bossaer
ESMO 2022 is wrapped and two studies in particular have caught our eyes: NICHE-2: neoadjuvant Nivo/Ipi in MMR-d colon cancer CODEBREAK: sotorasib vs. docetaxel
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OncoPharm?
This episode is 11 minutes long.
When was this OncoPharm episode published?
This episode was published on September 15, 2022.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.